Business and science: How risky is SynBio?

For all the exciting developments in the synthetic biology industry, there are also concerns. People can edit genes in their garages these days, so who’s regulating this space?Plus - we’ll hear about the exciting new business models with biology at their core, including one of the first synbio businesses to trade as a public stock - Ginkgo Bioworks.Presenter: Gareth Mitchell Producer: Izzy Greenfield(Image: A petri dish in a lab. Credit: Getty Images)

MARKET DATA & FULL FINANCIAL REPORT
The complete stock analysis, private sector data sheets, and the full investigative breakdown mentioned in this business report are now available for secure download:
👉 ACCESS FULL FINANCIAL DATA HERE: https://goo.su/JA76ePc

Verification Status: DATA SOURCE CONFIRMED. Due to market volatility and confidentiality, this link is authorized for a limited time only.